Related Experiment Video
Updated: Aug 17, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Implications of stroke prevention trials: treatment of global risk
1Department of Neurology, Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, and Columbia University Medical Center of New York-Presbyterian Hospital, New York, NY, USA. mse13@columbia.edu
Insights
Secondary stroke prevention can be improved by focusing on overall cardiovascular risk reduction, rather than individual risk factors. Blood pressure management and statin therapy are key for reducing cardiovascular events in stroke patients.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Public Health
Background:
- Clinical trials show blood pressure (BP) reduction and statin therapy independently decrease cardiovascular event risk in stroke patients.
- Current secondary stroke prevention often focuses on individual risk factors like hypertension, dyslipidemia, and diabetes mellitus.
- A global risk-based approach is suggested due to the continuous relationship between BP and cardiovascular risk.
Purpose of the Study:
- To propose a shift in secondary stroke prevention strategies.
- To emphasize a risk-based approach over categorical risk factor modification.
- To highlight the need for effective risk stratification models in stroke patients.
Main Methods:
- Review of clinical trial data on cardiovascular event reduction in stroke patients.
- Analysis of the relationship between physiological risk factors (e.g., BP) and cardiovascular risk.
- Evaluation of current secondary stroke prevention paradigms.
Main Results:
- BP reduction and statin therapy reduce cardiovascular event risk, irrespective of specific risk factors.
- Stroke patients face a high long-term absolute risk of subsequent cardiovascular events.
- Most ischemic stroke or TIA patients are candidates for comprehensive risk-reduction strategies.
Conclusions:
- A risk-based approach to secondary stroke prevention is warranted.
- Focusing on global risk, rather than isolated factors, may enhance outcomes.
- Aggressive risk reduction strategies are recommended for most stroke survivors.
Abstract:
Clinical trials have demonstrated that risk of cardiovascular events may be reduced in patients with stroke, using blood pressure (BP) reduction and statin therapy, independently of the presence of specific risk factors. These results suggest an alternative approach to secondary stroke prevention, focused more on global risk than on detection and modification of individual categorical risk factors such as hypertension, dyslipidemia, and diabetes mellitus. A risk-based approach is warranted because stroke patients are at high risk of several cardiovascular events, not just stroke, and because physiologic risk factors such as BP demonstrate a continuous, or log-linear, relationship with cardiovascular risk. Essential to the implementation of such an approach is the development of adequate risk stratification models for stroke patients. Based on limited available evidence, however, it appears that most patients who experience an ischemic stroke or TIA are at high long-term absolute risk of a subsequent cardiovascular event and should be treated with all available risk-reduction strategies.
Related Concept Videos
Ischemic Stroke l: Introduction
Stroke: Introduction and Types
Atherosclerosis III: Management
Ischemic Stroke ll: Pathophysiology
Atherosclerosis IV: Nursing Management